169 related articles for article (PubMed ID: 29165303)
1. Immunoreactivity to CYP24A1, but not vitamin D receptor, is increased in mast cells of keratinocyte skin cancers.
Kaukinen A; Siiskonen H; Pelkonen J; Harvima IT
Eur J Dermatol; 2017 Dec; 27(6):590-598. PubMed ID: 29165303
[TBL] [Abstract][Full Text] [Related]
2. Mast cells express CYP27A1 and CYP27B1 in epithelial skin cancers and psoriasis.
Kaukinen A; Pelkonen J; Harvima IT
Eur J Dermatol; 2015; 25(6):548-55. PubMed ID: 26463745
[TBL] [Abstract][Full Text] [Related]
3. CD40 Ligand Is Increased in Mast Cells in Psoriasis and Actinic Keratosis but Less So in Epithelial Skin Carcinomas.
Haimakainen S; Kaukinen AP; Suttle MM; Pelkonen J; Harvima IT
Cancer Invest; 2017 Mar; 35(3):143-151. PubMed ID: 28267402
[TBL] [Abstract][Full Text] [Related]
4. Mast Cells Are a Marked Source for Complement C3 Products That Associate with Increased CD11b-Positive Cells in Keratinocyte Skin Carcinomas.
Rahkola D; Laitala J; Siiskonen H; Pelkonen J; Harvima IT
Cancer Invest; 2019; 37(2):73-84. PubMed ID: 30689427
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin in skin carcinomas.
Tada H; Hatoko M; Muramatsu T; Shirai T
J Dermatol; 1996 Feb; 23(2):104-10. PubMed ID: 8839237
[TBL] [Abstract][Full Text] [Related]
6. Altered distribution of 1-2B7B antigen in basal cell carcinoma, squamous cell carcinoma and Bowen's disease.
Zhang XM; Horiguchi Y; Ueda M; Yoshiki T; Imamura S
J Dermatol Sci; 1992 Jan; 3(1):46-55. PubMed ID: 1591227
[TBL] [Abstract][Full Text] [Related]
7. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
10. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing hormone receptor-1 is increased in mast cells in psoriasis and actinic keratosis, but not markedly in keratinocyte skin carcinomas.
Haimakainen S; Harvima IT
Exp Dermatol; 2023 Oct; 32(10):1794-1804. PubMed ID: 37602923
[TBL] [Abstract][Full Text] [Related]
12. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
13. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
14. Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation.
Carvalho RF; Nilsson G; Harvima IT
Exp Dermatol; 2010 Feb; 19(2):117-22. PubMed ID: 19889021
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of Langerhans cells and expression of class II antigens on keratinocytes in malignant and benign epithelial tumors of the skin: an immunohistopathologic study with monoclonal antibodies.
Chen HD; Zhao YM; Sun G; Yang CY
J Am Acad Dermatol; 1989 Jun; 20(6):1007-14. PubMed ID: 2474010
[TBL] [Abstract][Full Text] [Related]
16. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
17. Altered keratin expression in benign and malignant skin diseases revealed with monoclonal antibodies.
Kariniemi AL; Virtanen I
Am J Dermatopathol; 1989 Jun; 11(3):202-8. PubMed ID: 2471415
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease.
Liao WT; Yu CL; Lan CC; Lee CH; Chang CH; Chang LW; You HL; Yu HS
Carcinogenesis; 2009 Jun; 30(6):1064-72. PubMed ID: 19376847
[TBL] [Abstract][Full Text] [Related]
19. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
Wu X; Cheng J; Yang K
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]